Abstract
Background/Aims: Youth with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency develop cardiovascular disease (CVD) risk factors of obesity and hypertension. Carotid intima-media thickness (CIMT), a marker of CVD risk, is increased in CAH young adults. We examined CIMT and its relationship with androgens and obesity in adolescents/young adults with CAH. Methods: Twenty CAH subjects (age 16 ± 3.3 years, 50% female) and 20 matched controls were studied cross-sectionally. Eight additional obese patients with CAH were included in within-group comparisons. CIMT by high-resolution ultrasound, androgens, anthropometry, bone age (BA), and metabolic/inflammatory markers were assessed. Results: Within the CAH group, CIMT correlated with 17-hydroxyprogesterone (r = 0.48, p < 0.05) and androstenedione (r = 0.46, p < 0.05), and was greater in obese subjects. CIMT was greater in CAH males than females, but similar among CAH females with advanced BA, CAH males with normal BA, and control males. There was no difference in CIMT between CAH and controls, although high-density lipoprotein was inversely correlated with CIMT in both groups. Conclusion: CIMT is associated with increased androgens in CAH adolescents and young adults, with loss of sex differences in CAH females with excess androgen exposure. Our findings highlight the importance of hormonal control for CVD prevention in CAH.
References
1.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-1437.
[PubMed]
2.
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
[PubMed]
3.
Mittelman SD, Gilsanz P, Mo AO, Wood J, Dorey F, Gilsanz V: Adiposity predicts carotid intima-media thickness in healthy children and adolescents. J Pediatr 2010;156:592-597.
[PubMed]
4.
Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS: Waist circumference, abdominal obesity, and depression among overweight and obese US adults: National Health and Nutrition Examination Survey 2005-2006. BMC Psychiatry 2011;11:130.
[PubMed]
5.
Volkl TM, Simm D, Beier C, Dorr HG: Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006;117:e98-e105.
[PubMed]
6.
Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, Reynolds JC, Hanna RM, Merke DP: Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2012;97:4429-4438.
[PubMed]
7.
Cornean RE, Hindmarsh PC, Brook CG: Obesity in 21-hydroxylase deficient patients. Arch Dis Child 1998;78:261-263.
[PubMed]
8.
Subbarayan A, Dattani MT, Peteres CJ, Hindmarsh PC: Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 2014;80:471-477.
[PubMed]
9.
Sartorato P, Zulian E, Benedini S, Mariniello B, Schiai F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C: Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007;92:1015-1018.
[PubMed]
10.
Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO: The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014;171:1-29.
[PubMed]
11.
Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO: Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2012;18:112-126.
[PubMed]
12.
Harrington J, Pena AS, Gent R, Hirte C, Couper J: Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction. Clin Endocrinol 2012;76:837-842.
[PubMed]
13.
Wasniewska M, Balsamo A, Valenzise M, Manganaro A, Faggioli G, Bombaci S, Conti V, Ferri M, Aversa T, Cicognani A, De Luca F: Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia. J Endocrinol Invest 2013;36:12-15.
[PubMed]
14.
Amr NH, Ahmed AY, Ibrahim YA: Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia. J Endocrinol Invest 2014;37:1001-1008.
[PubMed]
15.
Falkner B: The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Bethesda, National Heart Lung and Blood Institute, 2005, pp 1-48.
16.
Chobanian A: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, National Heart Lung and Blood Institute, 2004, pp 1-86.
[PubMed]
17.
McDowell MA, Fryar CD, Ogden CL: Anthropometric reference data for children and adults: United States, 1988-1994. Vital Health Stat 2009;249:1-68.
[PubMed]
18.
Gonzalez J, Wood JC, Dorey FJ, Wren TA, Gilsanz V: Reproducibility of carotid intima-media thickness measurements in young adults. Radiology 2008;247:265-271.
[PubMed]
19.
Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press, 1959.
20.
Faul F, Erdfelder E, Buchner A, Lang AG: Statistical power analysis using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149-1160.
[PubMed]
21.
Kim MS, Merke DP: Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Semin Reprod Med 2009;27:316-321.
[PubMed]
22.
Mendis S, Puska P, Norrving B (eds): Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, World Health Organization, World Heart Federation, and World Stroke Organization, 2011.
23.
Jones TH, Saad S: The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009;207:318-327.
[PubMed]
24.
Kanayama G, Pope HG Jr: Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes 2012;19:211-219.
[PubMed]
25.
Wild RA, Applebaum-Bowden D, Demers LM, Bartholomew M, Landis JR, Hazzard WR, Santen RJ: Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem 1990;36:283-289.
[PubMed]
26.
Dokras A: Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med 2008;26:39-44.
[PubMed]
27.
Macut D, Bacevic M, Bozic-Antic I, Bjekic-Macut J, Civcic M, Erceg S, Milutinovic DV, Stanojlovic O, Andric Z, Kastratovic-Kotlica B, Sukilovic T: Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure. Int J Endocrinol 2015;2015:812610.
[PubMed]
28.
Huppert J, Chiodi M, Hillard PJ: Clinical and metabolic findings in adolescent females with hyperandrogenism. J Pediatr Adolesc Gynecol 2004;17:103-108.
[PubMed]
29.
Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A: Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 2004;160:540-548.
[PubMed]
30.
Wang L, Szklo M, Folsom AR, Cook NR, Gapstur SM, Ouyang P: Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2012;224:228-234.
[PubMed]
31.
Mäki-Petäjä KM, Wilkinson IB: Inflammation and large arteries: potential mechanisms for inflammation-induced arterial stiffness potential mechanisms for inflammation-induced arterial stiffness. Artery Res 2012;6:59-64.
32.
Costa TJ, Ceravolo GS, dos Santos RA, de Oliveira MA, Araujo PX, Giaguinto LR, Tostes RC, Akamine EH, Fertes ZB, Dantas AP, Carvalho MH: Association of testosterone with estrogen abolishes the beneficial effect of estrogen treatment by increasing ROS generation in aorta endothelial cells. Am J Physiol Heart Circ Physiol 2015;308:H723-H732.
[PubMed]
33.
Labruijere S, van Houten ELAF, de Vries R, Musterd-Bagghoe US, Garrelds IM, Kramer P, Danser AHJ, Villalon CM, Visser JA, Van Den Brink AM: Analysis of the vascular responses in a murine model of polycystic ovary syndrome. J Endocrinol 2013;218:205-213.
[PubMed]
34.
Kim MS, Ryabets-Lienhard A, Dao-Tran A, Mittelman SD, Gilsanz V, Schrager SM, Geffner ME: Increased abdominal adiposity in adolescents and young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2015;100:E1153-E1159.
[PubMed]
35.
Bekdas M, Kaya E, Dagistan E, Goksugur SB, Demircioglu F, Erkocoglu M, Dilek M: The association of obesity and obesity-related conditions with carotid extra-medial thickness in children and adolescents. Pediatr Obes 2015, Epub ahead of print.
[PubMed]
36.
Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ: Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011;364:127-135.
[PubMed]
37.
Okumura K, Tsukamoto H, Tsuboi H, Hirayama H, Kamiya H, Watarai M, Ishiki R, Murohara T: High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness. Heart Vessels 2015;30:154-161.
[PubMed]
38.
Von Eckardstein A, Rohrer L: Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol 2009;20:197-205.
[PubMed]
39.
Breton CV, Wang X, Mack WJ, Berhane K, Lopez M, Islam TS, Feng M, Hodis HN, Künzli N, Avol E: Carotid artery intima-media thickness in college students: race/ethnicity matters. Atherosclerosis 2011;217:441-446.
[PubMed]
40.
Sprung VS, Atkinson G, Cuthbertson DJ, Pugh CJA, Aziz N, Green DJ, Cable NT, Jones H: Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol 2013;78:438-446.
[PubMed]
41.
Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD: Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410-1415.
[PubMed]
42.
Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ: Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110-5121.
[PubMed]
43.
Falhammar H, Frisen L, Linden Hirschberg A, Norrby C, Almqvist C, Nordenskjold A, Nordenstrom A: Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J Clin Endocrinol Metab 2015;100:3520-3528.
[PubMed]
© 2016 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2016
You do not currently have access to this content.
